Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 Biomarker group BEFREE Infectious stress triggers a POLG-related mitochondrial disease. 31655921 2020
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 Biomarker group BEFREE Among adult POLG1-associated mitochondrial disease, the main clinical feature is chronic progressive external ophthalmoplegia. 30936349 2019
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE POLG mutations are the most common cause of inherited mitochondrial disorders, with as many as 2% of the population carrying these mutations. 30451971 2019
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE Subsequent Sanger sequencing of POLG in a further 275 unrelated probands with genetically unconfirmed mitochondrial disease revealed a third unrelated proband with a similar phenotype harboring homozygous c.1879C>T; p.R627W mutations and a fourth patient, with a milder clinical disorder, harboring compound heterozygous POLG c.1879C>T; p.R627W and c.2341G>A; p.A781T mutations. 31425757 2019
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE PurposeMutations in POLG, the most common single-gene cause of inherited mitochondrial disease, are diagnostically challenging owing to clinical heterogeneity and overlap between syndromes. 28471437 2017
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 CausalMutation group CLINVAR Decreased male reproductive success in association with mitochondrial dysfunction. 28812649 2017
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 Biomarker group BEFREE POLG1 encodes mitochondrial DNA polymerase and is one of the causative genes for a Mendelian-inheritance mitochondrial disease, which is occasionally accompanied by mood disorders. 27987238 2017
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE Mutations in POLG have been linked to a spectrum of clinical phenotypes, resulting in autosomal recessive or dominant mitochondrial diseases. 28130605 2017
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 Biomarker group BEFREE Normal muscle and fibroblast studies do no exclude the diagnosis of POLG-related mitochondrial disease and direct sequencing of the POLG gene should be the gold standard when investigating suspected cases. 27554452 2016
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE Diseases due to mutations of POLG gene, encoding the mitochondrial DNA polymerase, are reputed to have very diverse clinical presentations and have been proposed to cause up to 25% adult mitochondrial diseases. 25118206 2015
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE We identified a mitochondrial disease causing missense variation in polymerase domain of POLG1 protein at amino acid 1143 (E1143G) to be 25 times more prevalent in European-Americans (allele frequency 0.03777) when compared to African-American (allele frequency 0.00151) population. 26468652 2015
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 Biomarker group BEFREE Clinical diagnosis of POLG-related disorders can be challenging because the phenotypic spectrums are heterogeneous which can mimic different types of mitochondrial disorders. 26169155 2015
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 Biomarker group BEFREE Fatal human herpesvirus 6-associated encephalitis in two boys with underlying POLG mitochondrial disorders. 25160553 2014
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE An analysis of the POLG1 gene should be performed for all patients with suspected mitochondrial disease before the introduction of valproate therapy, and treatment with valproic acid should be avoided in these patients. 25065347 2014
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 Biomarker group BEFREE Genes encoding the DNA helicase TWINKLE (C10orf2) or the two subunits of mtDNA polymerase γ (POLγ) (POLG1 and POLG2) have a direct effect on the mitochondrial DNA replication machinery and were reported in many mitochondrial disorders. 24011957 2014
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE Our clustering method provides a powerful tool to predict the pathogenic potential and predicted disease phenotype of novel variants and mutations in POLG, the most common nuclear gene underlying mitochondrial disorders. 24508722 2014
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 Biomarker group BEFREE Distal upper limb myopathy/cachexia is not previously described with dominant POLG mutations and our observations further highlight the diverse clinical spectrum of POLG-related mitochondrial disorders. 22933815 2013
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 Biomarker group BEFREE The aim of this study was to determine the prevalence of POLG mutations in an adult population of Australian patients with mitochondrial disease, displaying symptoms commonly associated with POLG-related diseases. 22647225 2013
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE Our findings suggest that the presence of HOD, in the appropriate clinical setting, should alert the clinician to the possibility of a mitochondrial disorder and the need to screen for mutations in POLG and SURF1 genes. 22729384 2013
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 Biomarker group BEFREE The combinatorial analyses of mtDNA and POLG revealed a diagnostic yield of 6.7% in patients with suspected mitochondrial disorders but no recognizable syndromes. 23463613 2013
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE Many mutations in POLG, the gene that encodes pol γ, have been associated with mitochondrial diseases such as myocerebrohepatopathy spectrum (MCHS) disorders, Alpers-Huttenlocher syndrome, myoclonic epilepsy myopathy sensory ataxia (MEMSA), ataxia neuropathy spectrum (ANS), and progressive external ophthalmoplegia (PEO). 23545419 2013
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE (1) Mitochondrial disorders(2) are a well-recognized cause; however, to our knowledge this is the first time that such extensive intracranial calcium deposits have been described in a patient with a POLG1 mutation. 23836942 2013
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE Mutations in POLG account for one of the most frequent nuclear encoded causes of mitochondrial disorders to date. 22405928 2012
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE Mitochondrial disorder was clinically suspected and a homozygous c.2243G>C mutation (p.Trp748Ser) was discovered in the POLG1 gene. 23248042 2012
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.500 GeneticVariation group BEFREE Alpers syndrome is one of the most common phenotypes of mitochondrial disorders in early childhood and has been associated with pathogenic mutations in POLG1. 22237560 2012